Clinical Trial Update: A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase I study evaluating safety, pharmacokinetics, and preliminary anti-tumor activity of evofosfamide (TH-302) in patients with advanced solid tumors; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Evofosfamide (evofosfamide)

Snippet

Sponsor: Threshold Pharmaceuticals | Conditions: Tumors, Hypoxia | Phase 1 | Status: COMPLETED